Livzon Pharma clarifies 2025 dividend: RMB14.30 per 10 shares, no bonus shares

Bulletin Express03-26

Livzon Pharmaceutical Group Inc. issued a supplemental announcement on 26 March 2026 to refine the proposed profit distribution plan for the financial year ended 31 December 2025.

The Board now specifies that a cash dividend of RMB14.30 (tax inclusive) will be paid for every 10 shares held, correcting any prior impression that RMB14.30 would be paid per single share. No bonus shares will be issued, and the capital reserve will not be converted into share capital.

The cash dividend will be calculated on the total share capital recorded on the equity registration date determined for the 2025 profit distribution. The proposal remains subject to approval at the forthcoming 2025 Shareholders’ Meeting.

All other information disclosed in the 24 March 2026 audited results announcement and the 2025 annual report remains unchanged.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155847396?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155847396","market":"hk","top_or_hot":-1,"title":"Livzon Pharma clarifies 2025 dividend: RMB14.30 per 10 shares, no bonus shares","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. issued a supplemental announcement on 26 March 2026 to refine the proposed profit distribution plan for the financial year ended 31 December 2025.</p>\n<p>The Board now specifies that a cash dividend of RMB14.30 (tax inclusive) will be paid for every 10 shares held, correcting any prior impression that RMB14.30 would be paid per single share. No bonus shares will be issued, and the capital reserve will not be converted into share capital.</p>\n<p>The cash dividend will be calculated on the total share capital recorded on the equity registration date determined for the 2025 profit distribution. The proposal remains subject to approval at the forthcoming 2025 Shareholders’ Meeting.</p>\n<p>All other information disclosed in the 24 March 2026 audited results announcement and the 2025 annual report remains unchanged.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma clarifies 2025 dividend: RMB14.30 per 10 shares, no bonus shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma clarifies 2025 dividend: RMB14.30 per 10 shares, no bonus shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-26 20:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. issued a supplemental announcement on 26 March 2026 to refine the proposed profit distribution plan for the financial year ended 31 December 2025.</p>\n<p>The Board now specifies that a cash dividend of RMB14.30 (tax inclusive) will be paid for every 10 shares held, correcting any prior impression that RMB14.30 would be paid per single share. No bonus shares will be issued, and the capital reserve will not be converted into share capital.</p>\n<p>The cash dividend will be calculated on the total share capital recorded on the equity registration date determined for the 2025 profit distribution. The proposal remains subject to approval at the forthcoming 2025 Shareholders’ Meeting.</p>\n<p>All other information disclosed in the 24 March 2026 audited results announcement and the 2025 annual report remains unchanged.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1155847396","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155847396","pubTimestamp":1774527872,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. issued a supplemental announcement on 26 March 2026 to refine the proposed profit distribution plan for the financial year ended 31 December 2025. The Board now...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药明确2025年分红：每10股14.30元，不送红股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. issued a supplemental announcement on 26 March 2026 to refine the proposed profit distribution plan for the financial year ended 31 December 2025.\nThe Board now specifies that a cash dividend of RMB14.30 (tax inclusive) will be paid for every 10 shares held, correcting any prior impression that RMB14.30 would be paid per single share. No bonus shares will be issued, and the capital reserve will not be converted into share capital.\nThe cash dividend will be calculated on the total share capital recorded on the equity registration date determined for the 2025 profit distribution. The proposal remains subject to approval at the forthcoming 2025 Shareholders’ Meeting.\nAll other information disclosed in the 24 March 2026 audited results announcement and the 2025 annual report remains unchanged.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155847396","isCrawlerRequest":true}